Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis: Report of five cases

Therapeutic Apheresis

Volumn 6, Issue 6, 2002, Pages 443-449

  Hasegawa, Midori ^a   Kawamura, Nahoko ^a   Kasugai, Masami ^a   Koide, Sigehisa ^a   Murase, Masamitsu ^a   Asano, Sinsuke ^a   Toba, Takako ^a   Kushimoto, Hiroko ^a   Murakami, Kazutaka ^a   Tomita, Makoto ^a   Shikano, Masahiko ^a   Sugiyama, Satoshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Associated vasculitis; Cytapheresis; Granulocytapheresis; Lymphocytapheresis; Myeloperoxidase antineutrophil cytoplasmic antibody

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; CYTAPHERESIS; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; LEUKAPHERESIS; LOW DRUG DOSE; LUNG HEMORRHAGE; MALE; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SIDE EFFECT; STEROID THERAPY; VASCULITIS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; GLOMERULONEPHRITIS; GLUCOCORTICOIDS; GRANULOCYTES; HUMANS; LEUKAPHERESIS; LUNG DISEASES; MALE; MIDDLE AGED; PEROXIDASE; PREDNISOLONE; VASCULITIS;

EID: 18744393721     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00462.x     Document Type: Article

References (9)

1. Jenette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated disease: A review. Am J Kidney Dis 1990;15:517-29.
2. Kashiwagi N, Asakura S, Ide T, Shibusawa H, Hiraishi K, Adachi M, Agishi T, Yoshino S, Kasukawa R. Effect of extracorporeal granulocytapheresis on antigen-induced arthritis in rabbits. Jpn J Inflammation 1994;14:313-22.
3. Kashiwagi N, Hirata I, Kaseukawa R. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 1998;2:134-41.
4. Sigematsu H, Yamaguchi Y, Koyama A. Glomerulointerstitial events in rapid progressive nephritic syndrome, with special reference to histologic grade and stage on the renal lesions. Clin Exp Nephrol 1998;2:330-8.
5. Cohen Tervaert JW, Stegeman CA, Kallenberg CG. Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Nephrol Hypertens 2001;10:211-7.
6. Falk RJ, Terrell RS, Charles LA, Nenete JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-9.
7. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmicautoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:23-32.
8. Green RJ, Ruoss SJ, Kraft SA, Duncan SR, Berry GJ, Raffin TA. Pulmonary capillaritis and alveolar hemorrhage: Update on diagnosis and management. Chest 1997;112:300.
9. Tanaka S, Kashiwagi N, Adachi M, Asano T, Nagamachi Y. Efficacy of extracorporeal granulotrap column (G-1column) in rabbit endotoxin shock models. Kitakanto Med J 1997;47:393-98.